Xcout IntelSign inSubscribe

Roche Holding AG competitors & alternatives

1ROGPharmaceuticalsChina

The 12 closest competitors and alternatives to Roche Holding AG among pharmaceuticals companies — ranked by similarity to what Roche Holding AG actually does, not by market-cap band.

12Competitors listed

Subscribe to see Roche Holding AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Roche Holding AG

Roche Holding AG is a healthcare company that develops and provides pharmaceuticals and diagnostic solutions to prevent, diagnose, and treat various diseases. The company primarily focuses on areas such as oncology, immunology, ophthalmology, infectious diseases, and neurological conditions, serving patients, healthcare professionals, and health systems globally.

Roche Holding AG at a glance

Roche Holding AG is a pharmaceuticals company headquartered in China. Xcout tracks 23 named people at Roche Holding AG, including Dr Thomas Schinecker (Chief Executive Officer Roche Group).

Roche Holding AG leadership

  • Dr Thomas SchineckerChief Executive Officer Roche Group
  • Matt SauseCEO Roche Diagnostics
  • Teresa GrahamCEO Roche Pharmaceuticals
  • Dr Alan HippeChief Financial Officer
  • Cristina A. WilburChief People Officer
  • Dr Levi GarrawayHead of Global Product Development and Chief Medical Officer

17 more named people on record for Roche Holding AG, with roles, board committees and tenure — see the full roster →

Recent Roche Holding AG news

Top 12 Roche Holding AG competitors

Ranked by semantic similarity — how close each company is to Roche Holding AG by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

AC Immune SAACIU · PharmaceuticalsLausanne, Switzerland
63% matchPublic

Similar pharmaceuticals company

AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegenerative conditions rooted in protein misfolding, both preventatively and therapeutically. Leveraging its proprietary SupraAntigen and Morphomer platforms, the company engineers a range of vaccines, antibodies, and small molecules specifically designed to engage with aberrantly folded proteins implicated across various neurodegenerative disorders. Its pipeline features Crenezumab, a humanized, conformation-specific monoclonal antibody currently undergoing a Phase II clinical prevention trial for Alzheimer's disease (AD). Additionally, AC Immune is advancing ACI-24, an anti-Abeta vaccine candidate, which is in Phase II clinical evaluation for AD and has successfully completed a Phase Ib study for Down syndrome. Other key candidates include ACI-35, an anti-Tau vaccine candidate that has finished Phase Ib clinical assessment, and a Tau-positron emission tomography (PET) imaging tracer, also in Phase II development. Furthermore, the company is engaged in the research and development of small molecule inhibitors to prevent Tau aggregation, targeting AD and various NeuroOrphan indications. Early-stage efforts include discovery and preclinical programs for a spectrum of neurodegenerative diseases, encompassing diagnostic agents aimed at TDP-43, alpha-synuclein, and NLRP3. The company maintains strategic partnerships and licensing agreements with key industry players such as Genentech, Inc., Biogen International GmbH, Janssen Pharmaceuticals, Inc., Life Molecular Imaging SA, Eli Lilly and Company, and WuXi Biologics. Founded in 2003, AC Immune S.A. is headquartered in Lausanne, Switzerland.

Market cap$295.1M
Employees133
AC Immune SA competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Roche Holding AG and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Roche Holding AGand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →